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Abstract
Introduction: the treatment for venous ulcers in most cases is unsatisfactory, with recurrences 
and poor healing. 
Objective: to evaluate adjuvant therapy in the treatment of active venous ulcers.
Methods: We analyzed 20 patients with active venous ulcers attending the general Surgery out-
patient clinic at the “Dr. José eleuterio gonzález” University Hospital from October 2012 to 
January 2013. they were randomly divided into 2 groups: group A (11 patients) underwent 
compression therapy and group B (9 patients) underwent compression therapy plus removal of 
the vein that gives terminal relux to the ulcer, guided by ultrasound (microphlebectomy). Pa-
tients were evaluated weekly (8 weeks). At each assessment, photographs and lesion measure-
ments were taken and pain was evaluated using the visual analog scale.
Results: No significant differences were found between the study groups in terms of age, 
weight, height, body mass index (BMi), ankle-brachial index, and baseline measurement of the 
ulcer (p>0.05). Group B showed a greater reduction in ulcer size and a statistically signiicant 
lower score on the visual analog pain scale (p<0.05) from the second and third week of 
treatment, respectively.
Conclusions: the results obtained in patients with surgical procedure (group B) are consistent 
with the reported eficacy of chronic venous ulcer treatment with saphenectomy (conventional 
surgery), the difference is that in this study we used a minimally invasive procedure (microphle-
bectomy).
1665-5796 © 2014 revista Medicina Universitaria. Facultad de Medicina UANL. Publicado por elsevier México. todos 
los derechos reservados.
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Introduction
A venous ulcer is the most serious consequence of chronic 
venous insuficiency. This disease has been known for over 
3500 years. Nowadays, it is a pathology which draws little 
attention, despite new indings regarding its pathogenesis 
and treatment. in our opinion, we should focus on its hea-
ling rather than on the cause of the problem. About 1% of 
the population has a history of Postphlebitic ulcers. this 
percentage increases to 4% in the population over 65.1 the 
Bonn Vein Study included 3072 participants, inding changes 
in pigmentation or eczema in 2.9% and a postphlebitic ul- 
cer in 0.7%.2 A multicenter study conducted in Poland with 
40,085 participants found skin changes in 4.6% of the patients, 
a healed ulcer in 1% and active ulcers in 0.5%.7 Heit et al. 
found a venous ulcer incidence of 18 for every 100,000 people 
a year and a yearly Billion-dollar expenditure on public health.3 
Current theories about the etiology of severe chronic ve-
nous insuficiency are related to chronic venous hyperten-
sion.4,5 When weakness develops in the walls of the veins, 
dilatation of the valve ring is produced, impeding valve 
coaptation.6 recent data indicates that venous hypertension 
causes extravasation of macromolecules and erythrocytes 
inside the interstitium.7,8 erythrocytes and protein intersti-
tial degradation are a powerful leucocyte chemoattractant. 
this suggests a role in cytokines, demonstrated by the pre-
sence of beta growth factor, which may cause ibrosis by 
stimulation of the extracellular matrix, reducing oxygen and 
nutrient circulation thus resulting in changes in the color 
and consistency of the skin.5
Advanced isolated venous insuficiency includes a sensa-
tion of excessive weight on the legs as well as edema. Signs 
include a phlebostatic crown (spider-shaped outbreak con-
sisting of small varicose intradermal veins on the medial as-
pect of the ankle and foot), and changes in skin such as 
lipodermatosclerosis, which in its chronic phase develops 
as shiny, hardened and pigmented skin.9,10 Ulcers have irre-
gular edges with neo-epithelization with a pinkish base with 
granulation tissue, on occasions with a ibrin coating. Pulse 
palpation and the ankle-brachial index test are necessary in 
order to rule out an arterial insuficiency.11,12 the Doppler 
ultrasound is currently the gold standard in venous insufi-
ciency diagnosis.13,14 The American Venous Forum classiies 
active venous ulcers as C6.15,16
treatment includes general measures: patient education, 
weight loss, elevation of the extremity and exercise.17-20 
Factors like immunosuppression, malnutrition, diabetes me-
llitus, arterial insuficiency, local infection, and cardiac in-
suficiency may affect ulcer healing. A compressive therapy 
is the base in venous ulcer treatment, and this has been 
validated in random studies.21 
O’Meara et al. and Ukat et al., proved a statistically signi-
icant decrease in time in ulcer healing (p=0.005) with the 
use of multiple elastic bandages compared to the inelastic 
systems.22-24 Myers et al. found supericial venous insufi-
ciency with Doppler ultrasound in 38% of the patients with 
venous ulcers, and a combination of supericial and deep ve- 
nous insuficiency in 48% of the patients with ulcers.25 A stu-
dy showed venous ulcer healing in 77% of the cases 12 
months after supericial venous relux surgical treatment.26 
Bush included 14 patients with chronic venous ulcers (6 to 
24 months) treated with compressive therapy. the patients 
were treated with the terminal interruption of relux sour-
ce technique guided by a Doppler ultrasound, which consis-
ted of injecting sclerosant foam into the ulcers proximal 
veins, with an ulcer healing time of 6 to 8 weeks in 11 pa-
tients, with 5 years with no recurrences in 7 patients, 2 
years with no recurrences in 4 patients, a year with no recu-
rrences in 2 patients and recurrence in one of them.27 
the objective of this study is to assess the clinical bene-
fits in reducing the size and pain in active venous ulcers 
using terminal interruption of relux source technique gui-
ded by ultrasound in the treatment of venous ulcers. 
Materials and methods
We performed a prospective, comparative longitudinal stu-
dy. A non-blind, experimental, controlled clinical trial.
Inclusion criteria: A C6 classiication by The American Ve-
nous Forum (active venous ulcers), age of at least 18 years, 
venous insuficiency diagnosed by a Doppler ultrasound, BMI 
between 18.5 and 34.9, no local infection, a signed infor-
med consent, having no previous venous surgery and an 
ankle-brachial index over 0.85.
We analyzed 20 patients with a diagnosed venous ulcer in 
their lower limbs, with a previously signed consent form, 
attending the general Surgery outpatient clinic at the “Dr. 
José eleuterio gonzález” University Hospital, and meeting 
the inclusion criteria, from October 2012 to January 2013. 
the patients were randomly divided into 2 groups: group A 
(control) with compression therapy and group B with surgi- 
cal treatment in addition to compressive therapy (expe- 
rimental). Patients were evaluated weekly (8 weeks). At each 
assessment, photographs and lesion measurements were 
taken and pain was evaluated using the visual analog scale. 
We indicated rest and elevation of lower extremities for 30 
minutes in the morning and 30 minutes in the afternoon, as 
Figure 1 echographic image showing the veins that give ter-
minal relux to the venous ulcer.
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well as sleeping with the affected limb elevated. Patients we- 
re discharged on an outpatient basis with analgesic (para-
cetamol 500 mg orally every 8 hours) in case of pain, and 
treating the wound every 24 hours with a super-oxidized 
antiseptic solution (Microdacyn®), non-adherent dressings 
and mild compression elastic socks (20-30 mmHg). 
in group B, using an ultrasound with lineal transducer of 
7.5 MHz, with the patient standing, the researcher looked 
for and marked the responsible vein(s) of the terminal blood 
relux to the ulcer (Fig. 1). Once we identiied the vein(s), 
we proceeded with: iniltration with local anesthesia (lido-
caine 1%), a puncture with a Jelco® catheter #14 adjacent 
to the marked vein, dermis dissection and vein extraction 
with a hook (Fig. 2), avulsion of the vein with hemostat 
clamps (Fig. 3), compression in order to achieve hemostasis, 
application of a super-oxidized antiseptic solution (Microda-
cyn®), non-adherent dressings and mild compression elastic 
socks (20-30 mmHg). 
Statistical analysis
the information was gathered in a database using excel®. 
We performed the Kolmogorov-Smirnov test to evaluate the 
variable distribution, and we determined that they all 
showed a normal distribution (gaussian). the other test 
used to compare both groups was the Student’s t-test with a 
95% conidence, and we considered it to be statistically sig-
niicant p<0.05. We used the SPSS® Statistics version 20.0 
(iBM Company). the study was approved by the institution’s 
Committee of ethics.
Results
A total of 20 patients with active venous ulcers were inclu-
ded, 11 of them -9 female and 2 male- in group A (compres-
sive therapy), and 9 of them -8 female and 1 male- in group 
B (surgical and compressive therapy). No signiicant diffe-
rences were found between the study groups in terms of 
age, weight, height, BMi, ankle-brachial index, and baseline 
measurement of the ulcer (table 1). Venous ulcer mean diame- 
ter in week 1 was 4.04 cm (± 2.44) for group A and 4.75 cm 
(± 3.75) for group B with a p=0.616 (table 2). group B 
showed a greater reduction in ulcer size and a statistically 
signiicant lower score on the visual analog pain scale com-
pared to group A (p<0.05) with full healing (scarring) in 
3 patients. This difference was signiicant from the second 
and third week of treatment, respectively (table 3).
the average reduction in ulcer size during 8 weeks of fo-
llow-up for group A (compressive therapy) was 1.9 cm and 
for group B (compressive therapy and surgical treatment) 
was 3.4 cm with a conidence interval of 95% (Fig. 4).
Discussion
Based on this study, we were able to ind that the medical-
surgical technique shown is better than the more conserva-
tive medical option. Favoring the results is the fact that no 
signiicant differences were found between the study groups 
in terms of age, weight, height, BMi, ankle-brachial index, 
and baseline measurement of the ulcer. Although patients in 
group B were younger (median age 58.44 years) than those 
in group A (median age 70.27 years), age wasn’t signiicantly 
distinct. All this makes the possibility of distractor variables 
that could alter the inal result less likely. Group B (medical 
and surgical therapy) showed a statistically signiicant re-
duction in ulcer size and complete healing (scarring) in 3 
Figure 2 image showing the extraction with a hook of the vein 
with terminal relux to the venous ulcer.
Figure 3 image showing the avulsion of the vein with terminal 
relux to the venous ulcer with a hemostatic clamp.
Table 1 Demographic data
Variable group A (n=11) group B (n=9) p
Age, years, 
average (± SD)
70.27 (± 16.3) 58.44 (± 14.2) 0.113
Weight, kg,  
MeDiAN (± SD)
76.36 (± 12.57) 77.77 (± 6.74) 0.766
Height, m, 
average (± SD)
1.62 (± 0.057) 1.62 (± 0.073) 0.900
BMi, kg/m2, 
average (± SD)
28.98 (± 4.46) 29.44 (± 2.14) 0.780
ABi, mmHg, 
average (± SD)
0.98 (± 0.087) 0.958 (± 0.06) 0.549
SD: standard deviation; BMi: body mass index; ABi: ankle-
brachial index.
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patients compared with group A. As Bush proves in his study 
with ulcer treatment at 8 weeks (11 patients out of the 14 
initially included), group B showed a lower score in the vi-
sual analog scale of pain compared with group A, which was 
statistically signiicant from the third week of treatment.27
Considering the satisfactory evolution in group B with a 
statistically signiicant decrease in pain and ulcer size, it 
would be convenient to extend follow-up in order to evalua-
te complete healing in every patient within this group in 
particular. in addition, it is important to determine venous 
ulcer recurrence between both groups in order to demons-
trate if there is a signiicant difference, as mentioned by 
the Landmark study eSCHAr (effect of Surgery and Com-
pression on Healing and recurrence in patients with venous 
ulcers), which randomized 500 patients with advanced 
chronic venous insuficiency. The irst group included 258 
patients treated with compression, a second group with 
242 patients was treated with compression and surgery; a 
Table 2 Measurement of the greatest diameter of the venous ulcer and the difference between 1-week and the week of the 
evaluation.
Variable Group A (n=11) Group B (n=9) p
Measurement 1-week, cm, average (± SD) 4.04 (± 2.44) 4.75 (± 3.75) 0.616
Measurement week 1-week 2
Difference in cm, average (± SD)
0.38 (± 0.25) 0.76 (± 0.53) 0.023
Measurement week 1-week 3
Difference in cm, average (± SD)
0.64 (± 0.45) 1.31(± 0.75) 0.025
Measurement week 1-week 4
Difference in cm, average (± SD)
1.054 (± 0.75) 1.4 (± 0.82) 0.028
Measurement week 1-week 5
Difference in cm, average (± SD)
1.29 (± 0.88) 2.3 (± 0.97) 0.026
Measurement week 1-week 6
Difference in cm, average (± SD)
Measurement week 1-week 7
Difference in cm, average (± SD)
Measurement week 1-week 8
Difference in cm, average (± SD)
1.56 (± 0.93)
1.7 (± 0.97)
1.87 (± 1.02)
2.64 (± 1.13)
2.97 (±1.32)
3.4 (± 1.71)
0.025
0.023
0.023
SD: standard deviation.
Table 3 Values on the visual analog scale of the pain during follow-up weeks.
Variable group A (n=11) group B (n=9) p
VAP week, 1, average (± SD) 7 (± 1.18) 7.66 (± 1.32) 0.250
VAP week, 2, average (± SD) 5 (± 1.5) 4.77 (± 1.85) 0.774
VAP week, 3, average (± SD) 4.36 (± 1.2) 2.55 (± 1.23) 0.004
VAP week, 4, average (± SD) 3.81 (± 1.47) 1.33 (± 1.41) 0.001
VAP week, 5, average (± SD) 3.0 (± 1.73) 0.77 (± 1.2) 0.004
VAP week, 6, average (± SD) 2.9 (± 1.75) 0.55 (± 0.08) 0.002
VAP week, 7, average (± SD) 2.36 (± 1.5) 0.33 (± 0.70) 0.002
VAP week, 8, average (± SD) 2.27 (± 1.55) 0.33 (± 0.70) 0.003
VAP: visual analog pain; SD: standard deviation.
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Figure 4 Comparison of the reduction of the size of the ulcer 
in centimeters between groups A (compression therapy) and B 
(surgical and compressive therapy).
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recurrence after 12 months of 28% for the irst group com-
pared to 12% for the second group was found.28,29 the obtai- 
ned results in this study of patients who underwent surgical 
procedure (group B) concur with the eficacy reported by 
Zamboni et al. in a randomized study of 45 patients with 
venous ulcers, 24 patients with compressive therapy and 21 
patients with postsurgical use of elastic socks, with healing 
of 96% in a period of 63 days for the irst group compared 
with 100% healing in 31 days for the second group,30 with 
the difference that in our study we utilized a minimally in-
vasive procedure (microphlebectomy). even though a sam-
ple of 20 patients is small (this being the study’s main 
weakness), there is a clear tendency in favor of our experi-
mental group. Another limitation of this study is a relatively 
short follow-up period. Terminal interruption of relux sou-
rce technique guided by ultrasound proved with statistically 
signiicant results to be more effective than the more con-
ventional medical treatment to reduce pain and size of ve-
nous ulcers. The use of this surgical technique may be a 
promising line of minimal invasion in venous ulcer treatment 
in the immediate future. Further studies are required with 
this surgical technique and a longer follow-up period in or-
der to evaluate recurrences. 
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